The chemist and druggist [electronic resource] . t from daily low doseaspirin treatment. Prevention of stroke Aspirins potent anti - plateleteffect has been shown to reducethrombosis of the cerebral arteries( stroke). Transient ischemicattacks (TIAs) occur when tinyfragments of a building thrombusbecome lodged in the cerebralvasculature, and these are oftenprecursors to stroke. In a series ofrandomised studies in which aspirinsanti-platelet action was compared toplacebo in 10,000 people with a past history of stroke or TIAs, a highlysignificant reduction in the risk ofsuffering a subsequent
The chemist and druggist [electronic resource] . t from daily low doseaspirin treatment. Prevention of stroke Aspirins potent anti - plateleteffect has been shown to reducethrombosis of the cerebral arteries( stroke). Transient ischemicattacks (TIAs) occur when tinyfragments of a building thrombusbecome lodged in the cerebralvasculature, and these are oftenprecursors to stroke. In a series ofrandomised studies in which aspirinsanti-platelet action was compared toplacebo in 10,000 people with a past history of stroke or TIAs, a highlysignificant reduction in the risk ofsuffering a subsequent vascular eventwas demonstrated. The future foraspirin in vasculardisease Aspirins potential for large scaleprevention and treatment of one ofthe most important causes ofmorbidity and mortality in the westernworld - vascular disease - isbecoming increasingly clear. Today itis estimated that in the USA, up to 30million people with previous stroke,heart attack or existing peripheralvascular disease could benefit bytaking aspirin on a daily Cerebral artery thrombosisThat does not take into account themillions with other known risk factors,and those who have yet to present. Itis anticipated that in the future evenmore clinicians will recognise theimpact that aspirin can make onpeoples lives, and that more willmake use of its potentially life-savingbenefits. References: 1. BMJ 1994; 308 81-106. 2. BMJ1994;308:159-68 3. Lancet 1988, n ISIS-3 Update 1991, 2 1-7. 5. N Eng J Med 1989;321(3): 129-35 6. Circulation 1985, 72(6pt2):V155-60. 7. European Aspirin Foundation THE EUROPEAN ASPIRINFOUNDATION: IMPROVINGASPIRIN AWARENESS The European Aspirin Foundation aims toincrease the knowledge and understandingof aspirin, probably the worlds oldest and mostwidely used stimulating the distribution andexchange of information and discussionon all aspects of aspirin, including currentresearch and old and new therapeutic usesfor it. the European Aspirin Foundationhelps
Size: 1889px × 1323px
Photo credit: © The Reading Room / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: ., bookcentury1800, bookdecade185, booksubjectpharmacy, bookyear1859
